Clin Respir J. 2017 Jul 3. doi: 10.1111/crj.12662. [Epub ahead of print]
- 1
- FMUC - Faculty of Medicine, University of Coimbra, Portugal.
- 2
- CNC - Centre for Neuroscience and Cell Biology, University of Coimbra, Portugal.
- 3
- Unit of Pneumology A, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Abstract
PURPOSE:
The widespread consumption of coffee means that any biological effects from its use can lead to significant public health consequences. Chronic pulmonary diseases are extremely prevalent and responsible for one of every six deaths on a global level.
METHODS:
We searched major medical databases for studies reporting on the effects of coffee or caffeine consumption on a wide range of non-malignant respiratory outcomes, including incidence, prevalence, evolution or severity of respiratory disease in adults. Studies on lung function and respiratory mortality were also considered.
RESULTS:
We found fifteen studies, including seven cohort, six cross-sectional, one case control and one randomized control trial. Coffee consumption was generally associated with a reduction in prevalence of asthma. The association of coffee with natural honey was an effective treatment for persistent post-infectious cough. One case-control study found higher risk of chronic obstructive pulmonary disease (COPD) with coffee consumption. No association was found with the evolution of COPD or sarcoidosis. Coffee was associated with a reduction in respiratory mortality, and one study found improved lung function in coffee consumers. Smoking was a significant confounder in most studies.
CONCLUSIONS:
Coffee consumption was associated with some positive effects on the respiratory system. There was however limited available evidence, mostly from cross sectional and retrospective studies. The only prospective cohort studies were those reporting on respiratory mortality. These results suggest that coffee consumption may be a part of a healthy lifestyle leading to reduced respiratory morbidity. This article is protected by copyright. All rights reserved.
© 2017 John Wiley & Sons Ltd.
KEYWORDS:
COPD; asthma; caffeine; coffee; respiratory disease; systematic review
